Clinical trial
Post-Market Evaluation of the EVO ICL
NCT05538754 is registered in ClinicalTrials.gov with Staar Surgical Company as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Post-Market Evaluation of the EVO ICL
- Lead sponsor
- Staar Surgical Company
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- September 23, 2022
- Completion date
- October 4, 2023
- Enrollment
- 205 (actual)
- Sites
- 8
Conditions
As the registry lists them; a condition with its own page is linked.
myopia, myopic astigmatism